The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Puts Forward Principles on Patient Access to Care

ACR Puts Forward Principles on Patient Access to Care

March 17, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
melis; Tashatuvango/shutterstock.com

melis; Tashatuvango/shutterstock.com

The ACR has partnered with the American Medical Association (AMA) and over a dozen stakeholder groups to create a set of 21 principles to reform prior authorization protocols. This coalition represents hospitals, medical groups, patients, pharmacists and physicians with a unified goal of creating a more patient-centered, streamlined and transparent process for prior authorization.

You Might Also Like
  • ACR Puts Forward Principles on Patient Access to Care
  • Principles Would Streamline Prior Authorization Processes
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
Explore This Issue
March 2017
Also By This Author
  • Tips on Audits

According to a new AMA survey, every week a medical practice completes an average of 37 prior authorization requirements per physician, which takes a physician and their staff an average of 16 hours, or the equivalent of two business days, to process. More than a third of surveyed physicians reported having staff who work exclusively on prior authorization, and nearly 90% of surveyed physicians reported that prior authorization sometimes, often or always delays access to care.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Prior authorization is more than an administrative burden that can take providers away from their patients. When preapproval is required by insurers before patients can access certain drugs or treatments, it can harm patients by delaying or interrupting needed medical services.

Utilization review entities should offer a minimum of a 60-day grace period for any step therapy or prior authorization protocols for patients who are already stabilized on a particular treatment upon enrollment in the plan.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Further, no utilization review entity should require patients to repeat step therapy protocols or retry therapies failed under other benefit plans before qualifying for coverage of a current effective therapy.

These reform principles seek common sense solutions that call for guidelines based on clinical criteria and patient safety, not cost alone. View all 21 principles. You can help the ACR promote prior authorization reform by becoming a key contact. Learn more.

Filed Under: From the College, Practice Management Tagged With: AC&R, AMA, American College of Rheumatology, American Medical Association, Practice Management, principles, prior authorization, rheumatologist, rheumatologyIssue: March 2017

You Might Also Like:
  • ACR Puts Forward Principles on Patient Access to Care
  • Principles Would Streamline Prior Authorization Processes
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
  • EULAR 2014: Shorten Delay for Access to Rheumatologic Patient Care

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)